IRIX News and Press, IRIDEX Corporation From 01/14/21

Volt Information Sciences VOLT -17% erasing yesterday's gains post Q4 results.Live Ventures LIVE -12% erasing yesterday's gains post FY results.Takung Art (TKAT) -11%.Nano Dimension NNDM -10% after prices $332.5M direct offering.Viveve Medical (VIVE) -1...

Gainers: ArcLight Clean Transition (ACTCU) +80%.VOXX International (VOXX) +47%.BIOLASE (BIOL) +43%.Dolphin Entertainment (DLPN) +41%.ENGlobal (ENG) +39%.Zomedica (ZOM) +39%.IRIDEX (IRIX) +34%.AcelRx Pharmaceuticals (ACRX) +28%.La Jolla Pharmaceutical (LJPC) ...

Gainers: Zomedica (ZOM) +36%,  IRIDEX (IRIX) +34%, Biomerica (BMRA) +32%, La Jolla Pharmaceutical (LJPC) +29%, Tyme Technologies (TYME) +15%.Losers: Avinger (AVGR) -17%, TransEnterix (TRXC) -16%, PolarityTE (PTE) -14%, ...

La Jolla Pharmaceutical (LJPC) +62% on exclusive licensing agreement with PAIONVOXX International (VOXX) +56% after posting strong sales growth.T2 Biosystems (TTOO) +33% after the company says its T2SARS-CoV-2 Panel is capable of detecting multiple variants of the COVID-19 viru...

Gainers: [[VOXX]] +42.9%. [[IRIX]] +22.0%. [[PXLW]] +11.8%. [[QTRX]] +7.9%. [[GNMK]] +6.9%.Losers: [[RDHL]] -9.4%. [[LINC]] -6.1%. [[LMND]] -5.3%. [[APM]] -3.9%. [[REVG]] -3.6%. For further details see: VOXX, IRIX, RDHL and LINC among after-hours movers

IRIDEX (IRIX) provides preliminary total revenue expected to be $12.2M-12.4M, versus $11.8M in Q4 2019.Cash and cash equivalents of ~$11.6M as of January 2, 2021, representing a net cash burn of $0.3M in Q4 and $1M FY 2020.FY total revenue expected to be $36.2M-36.4M, ~16% below fis...

MOUNTAIN VIEW, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today provided preliminary unaudited operational and financial results for the fourth quarter and full year ended January 2, 2021. Fourth Quarter 2020 Total revenue expected to be $12....

Iridex Corp. seems to be at the initial stage of a growth inflection that could drive the stock up 175-625%. IRIX has a commercial product which could revolutionize glaucoma treatment, with an addressable market of $1.2 bil+. There are several catalysts to drive IRIX stock to fair...

Gainers: [[ISR]] +67.9%. [[CRNX]] +7.9%. [[SCPE]] +6.3%. [[SCYX]] +6.1%. [[ENSV]] +5.3%.Losers: [[MXC]] -11.5%. [[CLSD]] -10.0%. [[DWSN]] -9.9%. [[IRIX]] -8.9%. [[TITN]] -6.6%. For further details see: ISR, CRNX, MXC and CLSD among after-hours movers

Osmotica Pharmaceuticals OSMT -26% on FDA response letter.Big Rock Partners Acquisition (BRPA) -25%.Regional Health Properties (RHE) -18%.Gevo (GEVO) -15%.New Concept Energy (GBR) -15%.MoSys (MOSY) -13%.Oxbridge Re Holdings (OXBR) -10%.IRIDEX (IRIX) -10%.Equillium (EQ) -10%.Tenax Th...